[ad_1]
Wilson PG, Manji M, Neoptolemos JP. Acute pancreatitis as model of sepsis. J Antimicrob Chemother. 1998;41(suppl):51–63.
Iserman R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg. 1998;86:1020–4.
Tenner S, Sica G, Highes M, Noordhoek E, Feng S, Zinner M, et al. Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology. 1997;113:899–903.
McFadden DW. Organ failure and multiple organ system failure in pancreatitis. Pancreas. 1991;6(suppl):37–43.
Bradley EL, Allen K. A prospective longitudinal study of observation versus surgical intervention in the management of necrotizing pancreatitis. Am J Surg. 1991;161:19–25.
Davies MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg. 1997;84:920–35.
Malleo G, Mazzon E, Siriwardena AK, Cuzzocrea S. Role of tumor necrosis factor-alpha in acute pancreatitis: from biological basis to clinical evidence. Shock. 2007;28:130–40.
Papachristou GI, Clermont G, Sharma A, Yadav D, Whitcomb DC. Risk and markers of severe acute pancreatitis. Gastroenterol Clin North Am. 2007;36:277–96.
Dambrauskas Z, Gulbinas A, Pundzius J, Barauskas G. Value of the different prognostic systems and biological markers for predicting severity and progression of acute pancreatitis. Scand J Gastroenterol. 2010;45:959–70.
Zrnić IK, Milić S, Fisić E, Radić M, Stimac D. C-reactive protein and lactate dehydrogenase as single prognostic factors of severity in acute pancreatitis. Lijec Vjesn. 2010;129:1–4.
Maeda Keisuke. Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis. Pancreas. 2006;32:87–92.
Takeyama Y, Takase K, Ueda T, Hori Y, Goshima M, Kuroda Y. Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death. J Gastrointest Surg. 2000;4:379–87.
McNicol A, Israels SJ. Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets. 2008;8:99–117.
Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroumbakis IE, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol. 2001;96:776–81.
Balci SB, Aktas G. A Comprehensive Review of the role of hemogram-derived inflammatory markers in gastrointestinal conditions. Iran J Colorectal Res. 2022;10:75–86.
Cakır L, Aktas G, Mercimek OB, Enginyurt O, Kaya Y, Mercimek K. Are red cell distribution width and mean platelet volume associated with rheumatoid arthritis. Biomed Res. 2016;27:292–4.
Aktas G, Kocak MZ, Duman TT, Erkus E, Atak BM, Sit M, et al. Mean platelet volume (MPV) as an inflammatory marker in type 2 diabetes mellitus and obesity. Bali Med J. 2018;7:650–3.
Cakir L, Aktas G, Enginyurt O, Cakir SA. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Med Mediterranea. 2014;30:425–8.
A-Tel BM, Bilgin S, Kurtkulagi O, Kahveci G, Duman TT, Sagdic T, et al. Frailty in Diabetic subjects during COVID-19 and its Association with HbA1c, Mean platelet volume and Monocyte/ /Lymphocyte ratio. Clin Diabetol. 2022;11:119–26.
Aktas G, Cakiroglu B, Sit M, Uyeturk U, Alcelik A, Savli H, et al. Mean platelet volume: a simple indicator of chronic prostatitis. Acta Med Mediterranea. 2013;29:551–4.
Bilgin S, A-Tel BM, Kahveci G, Duman TT, Kurkulagi O, Yurum S, et al. Hypothyroidism is strongly correlated with Mean platelet volume and red cell distribution width. Natl J Health Sci. 2021;6:7–10.
Sincer I, Çekici Y, Cosgun M, Aktas G, Gunes Y, Erdal E, et al. Does Mean platelet volume decrease in the presence of coronary artery Fistula? Arq Bras Cardiol. 2019;113:71–6.
Mimidis K, Papadopoulos V, Kotsianidis J, Filippou D, Spanoudakis E, Bourikas G, et al. Alterations of platelet function, number and indexes during acute pancreatitis. Pancreatology. 2004;4:22–7.
Erbis H, Aliosmanoglu I, Turkoglu MA, Ay E, Turkoglu A, Ulger BV. Evaluating mean platelet volume as a new indicator for confirming the diagnosis of necrotizing pancreatitis. Ann Ital Chir. 2014;86:132–6.
Osada J, Werezczynska-Siemiatkowska U, Dabrowski A, Dabrowska MI. Platelet activation in acute pancreatitis. Pancreas. 2012;41:1319–24.
Ranson JH, Lackner H, Berman IR, Schinella R. The relationship of coagulation factors to clinical complications of acute pancreatitis. Surgery. 1977;81:502–11.
Rokkam VR, Kotagiri R, Secondary Thrombocytosis. [Updated 2021 Aug 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. http://www.ncbi.nlm.nih.gov/books/nbk560810/.
Mofidi R, Duff MD, Wigmore SJ, Madhavan KK, Garden OJ, Parks RW. Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg. 2006;93:738–44.
Jiang L, Ding W, Zhang M. The progressive increase of the platelet count in a patient with acute severe pancreatitis. Am J Emerg Med. 2017;35:191e1–2.
Takeda K, Yokoe M, Takada T, Kataoka K, Yoshida M, Gabeta T, et al. Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. J Hepatobiliary Pancreat Sci. 2010;17:37–44.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.
Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.
Mortele KJ, Wiesner W, Intriere L, Shankar S, Zou KH, Kalantari BN, et al. A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. Am J Roentgenol. 2004;183:1261–5.
Wu BU, Jahannes RS, Sun X, Tabak Y, Conwell DL, Banks PA. The early prediction of mortality in acute pancreatitis: a large population-based study. Gut. 2008;57:1698–703.
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102–11.
Frossard JL, Steer ML, Pator CM. Acute pancreatitis. Lancet. 2008;371:143–52.
Fujimura Y, Hirota M, Ichihara A, Takamori H, Baba H. Platelet count as a sensitive and convenient parameter for assessing the prognosis in acute pancreatitis. Pancreas. 2008;37:225–8.
Deng H, Yu X, Gao K, Liu Y, Tong Z, Liu Y, et al. Dynamic nomogram for predicting thrombocytopenia in adults with acute pancreatitis. J Inflamm Ress. 2021;14:6657–67.
Marshall JC, Cook DJ, Christon NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1632–52.
Umapathy C, Gajendran M, Mann R, Boregowda U, Theethira T, Elhanafi S, et al. Pancreatic fluid collections: clinical manifestations, diagnostic evaluation and management. Dis Mon. 2020;66:100986.
Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis: a prospective study. Gastroenterology. 1986;91:433–8.
Dellinger EP, Forsmark CE, Layer P, Lévy P, Maraví-Poma E, Petrov MS, et al. Determinant-based classification of acute pancreatitis severity: an international multidisciplinary consultation. Ann Surg. 2012;256:875–80.
Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis. 1996;7:157–61.
Papadopoulos VP, Filippou DK, Mimidis KP. Mean platelet volume in acute pancreatitis: a systematic review and meta-analysis. Annals of Gastroenterology. 2020;33:398–404.
Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: methodological issue. Platelets. 2002;13:301–6.
Lei JJ, Zhou L, Liu Q, Xiong C, Xu CF. Can mean platelet volume play a role in evaluating the severity of acute pancreatitis? World J Gastroenterol. 2017;23:2404–13.
Bautista AP, Buckler PW, Towler HM, Dawson AA, Bennett B. Measurement of platelet life span in normal subjects and patients with myeloproliferative disease with indium oxine labelled-platelets. Br J Haematol. 1984;58:679–87.
Blasi RADe, Cardelli P, Costante A, Sandri M, Mercieri M, Arcioni R. Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med. 2013;39:636–43.
|
Sources 2/ https://bmcgastroenterol.biomedcentral.com/articles/10.1186/s12876-023-02837-w The mention sources can contact us to remove/changing this article |
[ad_2]